Saturday Night Keynote Speaker

Dr. Peter H. Diamandis

X-Prize Founder and World-Renowned Innovator

PCRI is proud to announce that Dr. Peter H. Diamandis, a key figure in the development of the personal spaceflight industry and a leader in innovative thinking, will serve as the keynote speaker for the annual Saturday Night Dinner Gala.

Dr. Diamandis is on a mission to open space frontier for humanity, serving as the Chairman and CEO of the X PRIZE Foundation, which is famously known for awarding a $10 million reward to the team that created the first private spaceflight. The Foundation continues to unveil new X PRIZEs for projects in Exploration (Space and Underwater), Life Sciences, Energy & Environment, Education and Global Development, which have the potential to benefit humanity.

Dr. Diamandis developed the X PRIZE competitions with the hope of speeding radical breakthroughs that can ultimately change the way we see ourselves and how we live on this planet. He strongly believes that focused and talented teams in pursuit of a prize and acclaim can change the world.

After a full day of information about prostate cancer, the Saturday Night Gala will offer a respite from talk about the disease, with Dr. Diamandis sharing his belief in innovation, teamwork and the continuous potential for change. He serves as an inspiring reminder that anything is possible- and even the sky is not necessarily the limit!

Dr. Peter H. Diamandis – Biography

Dr. Diamandis is the Chairman and CEO of the X PRIZE Foundation (www.xprize.org), which awarded the $10,000,000 Ansari X PRIZE (www.xprize.org) for private spaceflight. Diamandis is now focused on building the X PRIZE Foundation into a world-class prize institute whose mission is to bring about radical breakthroughs for the benefit of humanity. The X PRIZE is now developing X PRIZEs in fields such as Genomics, Automotive, Education, Medicine, Energy, and Social arenas.

Diamandis is an international leader in the commercial space arena, having founded and run many of the leading entrepreneurial companies in this sector. Diamandis also serves as the CEO of Zero Gravity Corporation (www.gozerog.com) a commercial space company developing private, FAA-certified parabolic flight utilize Boeing 727-200 aircraft. He is the Chairman & Co-Founder of the Rocket Racing League (www.rocketracingleague.com). Diamandis is a co-founder and Director of Space Adventures (www.spaceadventures.com), the company which brokered the launches of four private citizens to the International Space Station.

In 1987, Diamandis co-Founded the International Space University (ISU) (www.isunet.edu) where he served as the University’s first managing director. Today he serves as a Trustee of the $30M ISU that is based in Strasbourg, France. Prior to ISU, Diamandis served as Chairman of Students for the Exploration and Development of Space (SEDS) an organization he founded at MIT in 1980. SEDS is the world’s largest student pro space organization.

Dr. Diamandis attended the Massachusetts Institute of Technology (MIT) where he received his undergraduate degree in molecular genetics and graduate degree in aerospace engineering. After MIT he attended Harvard Medical School where he received his M.D. In 2005 he has was also awarded an honorary Doctorate from the International Space University.

He is the winner of the 2006 (inaugural) Heinlein Award, the 2006 Lindbergh Award, the 2006 Wired RAVE Award, the Konstantine Tsiolkovsky Award, twice the winner of the Aviation & Space Technology Laurel, and the 2003 World Technology Award for Space. In 8th grade, while living in New York, Dr. Diamandis won first place in the Estes rocket design contest.

Diamandis’ mission is to open the space frontier for humanity. His personal motto is: “The best way to predict the future is to create it yourself!”

 

Prostate Cancer Research Institute (PCRI)

Material provided by PCRI is intended for educational purposes for discussion with your physician and should not be considered as medical advice. Information and opinions expressed on this website are not an endorsement by PCRI for any treatment, product or service.